top of page
  • Patient Education

Patient Education: Carfilzomib (Kyprolis) - Proteasome Inhibitor

Patient Education: Carfilzomib (Kyprolis) - Proteasome Inhibitor

Carfilzomib (Kyprolis)

Carfilzomib


NIH National cancer institute - cancer.gov site info

This page contains brief information and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Kyprolis

FDA Approved: Yes

Learn more: https://www.cancer.gov/about-cancer/treatment/drugs/carfilzomib

 

MedlinePlus Information

A lay language summary of important information about this drug that may include the following:

warnings about this drug,

what this drug is used for and how it is used,

what you should tell your doctor before using this drug,

what you should know about this drug before using it,

other drugs that may interact with this drug, and

possible side effects.

Learn more: Carfilzomib Injection: MedlinePlus Drug Information

 

Information on Kyprolis website


https://www.kyprolis.com/what-to-expect#side-effects

https://www.kyprolis.com/what-to-expect

 

INTERNATIONAL MYELOMA FOUNDATION:


Understanding Carfilzomib (Kyprolis)

https://www.myeloma.org/resource-library/understanding-kyprolis-carfilzomib-injection

Download Booklet here


IMF Understanding Series

https://www.myeloma.org/cancer-information-series


IMF Resource Library

https://www.myeloma.org

https://www.myeloma.org/publications-videos

https://www.youtube.com/c/IMFMyeloma/videos


Current FDA-Approved Medications for Multiple Myeloma Treatment

https://www.myeloma.org/multiple-myeloma-drugs

 

HEALTH TREE UNIVERSITY MYELOMA:


All About Kyprolis (Carfilzomib)

Watch Video on YouTube


HealthTree University for Multiple Myeloma Lectures


https://healthtree.org/myeloma/university/courses

https://healthtree.org/


Health Tree University Myeloma Videos

https://www.youtube.com/c/HealthTreeUniversity/videos

 

MULTIPLE MYELOMA RESERACH FOUNDATION:


Standard Treatments - Carfilzomib (Kyprolis)

https://themmrf.org/multiple-myeloma/treatment-options/standard-treatments/kyprolis/

https://themmrf.org/multiple-myeloma/treatment-options/standard-treatments/


MMRF Education Programs

https://themmrf.org/resources/education-programs/

https://themmrf.org/


MMRF Videos

https://www.youtube.com/user/TheMMRF/videos

 

References Velcade:


FDA Label Prescribing Information (Revised 11/2021)

kyprolis_pi.pdf (amgen.com)

label (fda.gov)


Drug Label Information at DAILYMED - NIH-National Library of Medicine

DailyMed - KYPROLIS- carfilzomib injection, powder, lyophilized, for solution (nih.gov)


Other Resources

Support & Resources | KYPROLIS® (carfilzomib)

 

- Multiple Myeloma Patient Education & Information on ongoing Multiple Myeloma Clinical Trials -

Posts Archive
bottom of page